Mr
Rudolf
Erhardt Sachs

Senior European Patent Attorney

Munich Office

Engineering

Telephone. +49(0) 891 259 9600
Email. [email protected]

Experience

Rudolf started in 1996 working in the IP business. His experience and interests cover a wide field of technologies, allowing him to quickly understand a matter and pinpoint its issues in the field between technical, legal, and economic constraints.

Rudolf’s work approach is fact-oriented, diligent and analytical. He is dedicated to an in-depth understanding of any factors contributing to a case, giving best possible advice to clients and finding a solution that meets their needs.

Qualifications

Patent Attorney

Europe
Germany


DIPL.-ING

Mechanical Engineering / Aerospace Technology

OTHER

Diploma Mechanical Engineering

Publications

From March 1 Patronus IP have merged with HGF

View publication online

Related News

Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Parallel importation of pharmaceuticals – when is repackaging necessary?

The repackaging of pharmaceutical products by parallel importers is a long debated subject. The above question was reconsidered in a set of judgements by the CJEU in November last year …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

Trade mark protection for digital health products

The use and creation of digital healthcare products is on the rise as companies look to create a unique selling point and a differentiator in a crowded market. One of …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.